Smith & Nephew (SNN) Income from Continuing Operations (2009 - 2024)
Smith & Nephew (SNN) reported Income from Continuing Operations of 253000000.0 for Q4 2024, up 19.91% on a YoY basis from 211000000.0 in Q1 2024, and up 19.91% quarter-over-quarter from 211000000.0 in Q4 2023.
Smith & Nephew (SNN) Income from Continuing Operations (2009 - 2024) Analysis & Trends
Smith & Nephew has reported Income from Continuing Operations for 16 years, with the latest figure at 253000000.0 in Q4 2024.
- For the quarter ending Q4 2024, Income from Continuing Operations rose 19.91% year-over-year to 253000000.0; the trailing twelve-month figure through Dec 2024 stood at 891000000.0 (up 47.52% YoY), and the FY2025 full-year result was 625000000.0, up 51.7% from the prior year.
- Income from Continuing Operations for Q4 2024 stood at 253000000.0, up from 211000000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 253000000.0 in Q4 2024, with the low at 34000000.0 in Q4 2020.
- Historically, Income from Continuing Operations has averaged 171400000.0 across 5 years, with a median of 211000000.0 in 2023.
- Annual changes were most pronounced in 2020 — Income from Continuing Operations tumbled 108.88% — and 2021, when it jumped 755.88%.
- Smith & Nephew's Income from Continuing Operations stood at 34000000.0 in 2020, then jumped by 755.88% to 223000000.0 in 2021, then dropped by 8.52% to 204000000.0 in 2022, then climbed by 3.43% to 211000000.0 in 2023, then advanced by 19.91% to 253000000.0 in 2024.
- The last three Income from Continuing Operations figures came in at 253000000.0 (Q4 2024), 211000000.0 (Q4 2023), and 204000000.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Smith & Nephew | 5.27 Bn | 4.69 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 253.00 Mn |
| Dec 31, 2023 | 211.00 Mn |
| Dec 31, 2022 | 204.00 Mn |
| Dec 31, 2021 | 223.00 Mn |
| Dec 31, 2020 | -34.00 Mn |
| Dec 31, 2019 | 383.00 Mn |
| Dec 31, 2018 | 341.00 Mn |
| Dec 31, 2017 | 383.00 Mn |
| Dec 31, 2016 | 327.00 Mn |
| Dec 31, 2015 | 411.00 Mn |
| Dec 31, 2014 | 1.03 Bn |
| Sep 30, 2014 | 153.00 Mn |
| Mar 31, 2014 | 212.00 Mn |
| Dec 31, 2013 | 204.00 Mn |
| Sep 28, 2013 | 180.00 Mn |
| Jun 29, 2013 | 188.00 Mn |
| Mar 31, 2013 | 232.00 Mn |
| Dec 31, 2012 | 231.00 Mn |
| Sep 29, 2012 | 187.00 Mn |
| Jun 30, 2012 | 475.00 Mn |